In a research conducted by the American Heart Association, it is stated that patients taking Vytorin have experienced a lesser number of heart attacks, strokes and hospitalizations than those who have just been taking statins. The study took under consideration 18,144 patients, who were under high risk and they had been taking Vytorin. The drug Vytorin is a combination of a statin and non-statin; Zocor and Zetia. It showed that this combination is a remedial intake in patients.
Dr. Christopher Cannon, who led the research, said the study shows that patients and doctors need to continue focusing on lowering cholesterol. “This reminds us that the cholesterol story is true and that lowering cholesterol reduces heart disease. The whole lesson we’ve had in the last 10 years is that some drugs that make your labs look better don’t necessarily improve your outcomes.” Cannon is a a cardiologist at Brigham and Women’s Hospital and professor at Harvard Medical School, both in Boston.
The American Heart Association and the American College of Cardiologists have only recommend statins for now as they lower the amount of LDL or bad cholesterol in the blood. Statins are also considered a kind of miracle drug in modern medicine. Stating fall under the most widely prescribed in the world, they are often able to lower a person’s cholesterol to very low levels with few noticeable side effects. However, the researchers have said that they do not work for all. They also have some side effects, like muscle pain, digestion problems and also damaging the liver.
The study was funded by Merck and was carried out in multiple parts around the world. Amongst the cardiovascular medicines around the globe, Vytorin has enjoyed the limelight of being the most controversial of all the drugs available. Merck and Schering-Plough had also been accused of suppressing negatives of the drug in the near past.